Acadia Pharmaceuticals | ACAD - Trade Debtors



Acadia Pharmaceuticals reported $119.69M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
ALKERMES USD 356.33M 34.58M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Corcept Therapeutics USD 64.57M 2.75M Jun/2025
Cytokinetics USD 8.41M 6.4M Jun/2025
Eisai JPY 219.98B 42M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Moderna USD 457M 151M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Prothena USD 0 0 Dec/2024
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025